B-cell lymphoproliferative disorders are rare but serious complications of solid organ and bone marrow transplantation. We report that these tumors frequently express the CD-20 antigen, and immunotherapy directed at this antigen may be a well-tolerated and effective treatment. (C) 2000 Wiley-Liss, Inc.
|Original language||English (US)|
|Number of pages||3|
|Journal||American Journal of Hematology|
|State||Published - Oct 5 2000|
- Post-transplant lymphoproliferative disorder
ASJC Scopus subject areas